173 related articles for article (PubMed ID: 8688148)
21. Molecular approaches towards an anti-ras drug.
Sigal IS; Smith GM; Jurnak F; Marsico-Ahern JD; D'Alonzo JS; Scolnick EM; Gibbs JB
Anticancer Drug Des; 1987 Oct; 2(2):107-15. PubMed ID: 3130069
[TBL] [Abstract][Full Text] [Related]
22. Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells.
Leblanc V; Delumeau I; Tocqué B
Oncogene; 1999 Aug; 18(34):4884-9. PubMed ID: 10490822
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
Gutmann DH; Boguski M; Marchuk D; Wigler M; Collins FS; Ballester R
Oncogene; 1993 Mar; 8(3):761-9. PubMed ID: 8437860
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to synthetic peptide from the residue 33 to 42 domain of c-Ha-ras p21 block reconstitution of the protein with different effectors.
Rey I; Soubigou P; Debussche L; David C; Morgat A; Bost PE; Mayaux JF; Tocque B
Mol Cell Biol; 1989 Sep; 9(9):3904-10. PubMed ID: 2550807
[TBL] [Abstract][Full Text] [Related]
25. GTPase mechanism and function: new insights from systematic mutational analysis of the phosphate-binding loop residue Ala30 of Rab5.
Liang Z; Mather T; Li G
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):501-8. PubMed ID: 10677372
[TBL] [Abstract][Full Text] [Related]
26. Plasma membrane-targeted ras GTPase-activating protein is a potent suppressor of p21ras function.
Huang DC; Marshall CJ; Hancock JF
Mol Cell Biol; 1993 Apr; 13(4):2420-31. PubMed ID: 8455619
[TBL] [Abstract][Full Text] [Related]
27. [NF1 (neurofibromatosis type 1)].
Maruta H; Nur-e-Kamal
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1422-6. PubMed ID: 9309135
[TBL] [Abstract][Full Text] [Related]
28. Individual rate constants for the interaction of Ras proteins with GTPase-activating proteins determined by fluorescence spectroscopy.
Ahmadian MR; Hoffmann U; Goody RS; Wittinghofer A
Biochemistry; 1997 Apr; 36(15):4535-41. PubMed ID: 9109662
[TBL] [Abstract][Full Text] [Related]
29. Rasp21 sequences opposite the nucleotide binding pocket are required for GRF-mediated nucleotide release.
Leonardsen L; DeClue JE; Lybaek H; Lowy DR; Willumsen BM
Oncogene; 1996 Nov; 13(10):2177-87. PubMed ID: 8950985
[TBL] [Abstract][Full Text] [Related]
30. A recombinant cell line expressing a form of the Y13-259 anti-p21ras antibody which binds protein A and may be produced as ascites.
Werge TM; Bradbury A; Di Luzio A; Cattaneo A
Oncogene; 1992 May; 7(5):1033-5. PubMed ID: 1570149
[TBL] [Abstract][Full Text] [Related]
31. Decreased GTPase activity of K-ras mutants deriving from human functional adrenocortical tumours.
Lin SR; Hsu CH; Tsai JH; Wang JY; Hsieh TJ; Wu CH
Br J Cancer; 2000 Mar; 82(5):1035-40. PubMed ID: 10737386
[TBL] [Abstract][Full Text] [Related]
32. Novel, activated RAS mutations alter protein-protein interactions.
Dalley BK; Cannon JF
Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
[TBL] [Abstract][Full Text] [Related]
33. GAP control: regulating the regulators of small GTPases.
Bernards A; Settleman J
Trends Cell Biol; 2004 Jul; 14(7):377-85. PubMed ID: 15246431
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction via Ras.
Wittinghofer A
Biol Chem; 1998; 379(8-9):933-7. PubMed ID: 9792425
[TBL] [Abstract][Full Text] [Related]
35. Control of ras activation.
Downward J
Cancer Surv; 1996; 27():87-100. PubMed ID: 8909796
[TBL] [Abstract][Full Text] [Related]
36. A conserved region of c-Ha-Ras is required for efficient GTPase stimulation by GTPase activating protein but not neurofibromin.
Yoder-Hill J; Golubic M; Stacey DW
J Biol Chem; 1995 Nov; 270(46):27615-21. PubMed ID: 7499225
[TBL] [Abstract][Full Text] [Related]
37. GTPase activating proteins.
Bollag G; McCormick F
Semin Cancer Biol; 1992 Aug; 3(4):199-208. PubMed ID: 1421164
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of yeast adenylate cyclase by antibodies to ras p21.
Gibbs JB; Marsico-Ahern JD; Scolnick EM; Sigal IS
Biochem J; 1988 May; 252(1):289-92. PubMed ID: 2458712
[TBL] [Abstract][Full Text] [Related]
39. The GAP1 family of GTPase-activating proteins: spatial and temporal regulators of small GTPase signalling.
Yarwood S; Bouyoucef-Cherchalli D; Cullen PJ; Kupzig S
Biochem Soc Trans; 2006 Nov; 34(Pt 5):846-50. PubMed ID: 17052212
[TBL] [Abstract][Full Text] [Related]
40. The role of the metal ion in the p21ras catalysed GTP-hydrolysis: Mn2+ versus Mg2+.
Schweins T; Scheffzek K; Assheuer R; Wittinghofer A
J Mol Biol; 1997 Mar; 266(4):847-56. PubMed ID: 9102473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
